ANAB
AnaptysBioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ANAB vs peer average
67/100
ANAB vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 5 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
REGN is the first available peer comparator.
Regeneron is a useful biologics and partner-commercialization benchmark for thinking about durability of antibody-driven cash flows, although it is far more diversified and not a pure royalty-management structure.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANAB
AnaptysBio
REGN
Regeneron
Grade
B
C
Momentum
83
25
Value
41
65
Sentiment
51
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs REGN
ANAB / REGN
Grade Position
In line
ANAB vs. peer average (B vs. C)
67/100
Momentum
83
ANABValue
41
REGNSentiment
51
REGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANAB
REGN is the first peer returned for this comparison set.